Author Archive - GEN - Genetic Engineering and Biotechnology News

Home Authors Posts by Alex Philippidis

Coalition Pursues Tax Breaks for Biotechs that Repatriate Revenue or Invest in R&D

Nagoya Protocol’s Rules for Genetic Resources Pose Challenges for U.S. Drug Developers

Facts Deceit Magnifying Glass

Language in Bill and Capitol Hill Politics Create Cloudy Outlook for Sunshine in Litigation Act

For Some Emerging Companies, the Road to Growth Connects the U.S. and China

U.S. Stem Cell Companies Find Partners and Revenues Beyond the Water’s Edge

Accounting and Finance

Tech Transfer Bill in the House Would Rewrite Key Bayh-Dole Provisions

Brain Drain and Need for New Infrastructure Loom as Challenges to Post-Quake Japan

Efforts to Standardize Molecular Imaging Blossoms as Industry and Agencies Unite

Prospect of Court Appeals and Congressional Bill Hold the Cards for hESC Research

As Comment Period Ends, FDA Seeks to Clarify Conflict of Interest Rules

Concurrent Dx/Rx Review Will Require More Collaboration at FDA and More Outreach by Industry

Advocates Attempt to Advance Regenerative Medicine with Introduction of HR 1862

Revival of Tax Credit Program Depends on Job Creation and Scientific Results

India’s Biotechnology Future—As Easy as R&D, as Challenging as China

Therasense v. Becton Dickinson Ruling Expected to Limit Inequitable Conduct Cases

Diagnostic Market Stakeholders Take Aim at FDA’s RUO/IUO Draft Guidance

ManufacturingFacility

CMOs Seek Growth Beyond Traditional Contract Manufacturing

House Version of Patent Reform Poses Challenges for Biotech Inventors

Genentech Prepares to Vouch for Avastin’s Use in Breast Cancer in FDA Hearing

What Does It Take to Swing the IPO Window Open for Biotechs?

< 1 … 163 164 165 166 167 > Page 165 of 167